home / stock / igxt / igxt quote
Last: | $0.167 |
---|---|
Change Percent: | 4.61% |
Open: | $0.1593 |
Close: | $0.167 |
High: | $0.169325 |
Low: | $0.1593 |
Volume: | 37,230 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.167 | $0.1593 | $0.167 | $0.169325 | $0.1593 | 37,230 | 05-16-2024 |
$0.1735 | $0.15955 | $0.1735 | $0.1735 | $0.15955 | 164,817 | 05-15-2024 |
$0.164 | $0.155 | $0.164 | $0.17 | $0.155 | 36,455 | 05-14-2024 |
$0.1648 | $0.173 | $0.1648 | $0.173 | $0.155 | 9,422 | 05-13-2024 |
$0.159 | $0.165425 | $0.159 | $0.165425 | $0.1586 | 15,607 | 05-10-2024 |
$0.17 | $0.15555 | $0.17 | $0.1705 | $0.1511 | 79,161 | 05-09-2024 |
$0.1561 | $0.18 | $0.1561 | $0.18 | $0.1501 | 429,966 | 05-08-2024 |
$0.19 | $0.19 | $0.19 | $0.19 | $0.17 | 23,552 | 05-07-2024 |
$0.19 | $0.16025 | $0.19 | $0.19 | $0.16025 | 223,211 | 05-06-2024 |
$0.1619 | $0.178 | $0.1619 | $0.179935 | $0.15884 | 136,907 | 05-03-2024 |
$0.1785 | $0.178375 | $0.1785 | $0.18 | $0.1775 | 34,778 | 05-02-2024 |
$0.18 | $0.1772 | $0.18 | $0.18 | $0.17 | 191,667 | 05-01-2024 |
$0.16212 | $0.16 | $0.16212 | $0.1795 | $0.15363 | 165,658 | 04-30-2024 |
$0.16 | $0.17 | $0.16 | $0.17 | $0.14644 | 442,571 | 04-29-2024 |
$0.16396 | $0.1675 | $0.16396 | $0.18 | $0.1501 | 60,179 | 04-26-2024 |
$0.16664 | $0.1676 | $0.16664 | $0.18 | $0.15 | 149,612 | 04-25-2024 |
$0.15 | $0.15 | $0.15 | $0.169 | $0.15 | 81,018 | 04-24-2024 |
$0.1639 | $0.165 | $0.1639 | $0.165 | $0.13955 | 398,613 | 04-23-2024 |
$0.1699 | $0.175 | $0.1699 | $0.175 | $0.155 | 43,904 | 04-22-2024 |
$0.165 | $0.155 | $0.165 | $0.17025 | $0.155 | 53,282 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA Alzheimer’s disease (AD) study. The BUENA study was designed as ...
MONTREAL, June 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “ Company ” or “ IntelGenx ” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), was granted protection pursuant to an order (as amended or amended and restated from time t...
MONTREAL, May 28, 2024 (GLOBE NEWSWIRE) -- As previously announced on May 17, 2024, IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing o...